Overview

To Determine if Chromium Nicotinate Supplementation Will Improve Insulin Resistance in HIV Patients With Metabolic Abnormalities

Status:
Completed

Trial end date:
2008-02-01

Target enrollment:

Participant gender:

Summary

In HIV patients, fasting insulin levels decrease with chromium supplementation. This study is to determine if chromium nicotinate supplementation at 400ug/day for 16 weeks will improve insulin resistance in HIV patients with metabolic abnormalities.

Phase:

Phase 2

Details

Lead Sponsor:

Johane Allard

Collaborator:

Canadian Foundation for AIDS Research (CANFAR)

Treatments:

Chromium
Niacin
Nicotinic Acids